HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Evaluation of fraxiparine efficacy in the treatment of retinal vein occlusion].

AbstractPURPOSE:
To evaluate the efficacy of Fraxiparine in the treatment of central retinal vein occlusion and retinal branch vein occlusion.
METHODS:
30 patients were treated. Fraxiparine (Sanofi-Pharma) was injected subcutaneously in doses of 7.5 thousand units twice daily for 10 days and once daily for 18 days. In 19 cases central retinal vein occlusion was observed and retinal branch vein occlusion in 11 cases. Mean follow-up was 15 months (range 10-35 months). Ophthalmological examination including fluorescein angiography was performed before and after therapy.
RESULTS:
Improvement of visual function and condition of retina after therapy was observed in about 50% of cases. In 16 patients laser photocoagulation applied for neovascularisation or retinal edema was necessary.
AuthorsB Romanowska, A Goszcz, L Grodzińska, K Bieroń, E Kostka-Trabka
JournalKlinika oczna (Klin Oczna) Vol. 101 Issue 6 Pg. 451-4 ( 1999) ISSN: 0023-2157 [Print] Poland
Vernacular TitleOcena skuteczności fraksyparyny w leczeniu niedrozności zył siatkówki.
PMID10786054 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anticoagulants
  • Nadroparin
Topics
  • Adult
  • Aged
  • Angiography (methods)
  • Anticoagulants (therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Nadroparin (therapeutic use)
  • Retinal Vein Occlusion (diagnostic imaging, drug therapy)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: